Revaprevent SRL
Revaprevent reported total assets of €1.58m at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026).
The score of Revaprevent shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets +22 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Revaprevent's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jul 2026
- Year ended 31 Dec 2024filed on 02 Jul 2025
- Year ended 31 Dec 2023filed on 11 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
- Year ended 31 Dec 2021filed on 18 Jul 2022
Revaprevent's financial analysis
- Solvency96.3%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Revaprevent
Revaprevent's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0832.428.660
- VAT number
- BE0832428660
- Peppol
- Registered · 0208:0832428660 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Dec 2010
- Registered office
- 8800 Roeselare
- Latest accounts
- 2025 · filed on 16 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Revaprevent (SRL) has been based in Roeselare since 2010, active in: medical specialists activities. For 2025, it reports a net profit of 181,088 € and equity of €1.52m; its revenue is not published. Its solvency stands at 96.3%, above the median of its sector (72.2%).
Companies similar to Revaprevent
Companies in the same business, of comparable size and area, outside its group.
- Gryspeerdt Stefaan Medical specialists activities Roeselare · balance sheet €1.48m
- DR. L. Delsupehe Medical specialists activities Roeselare · balance sheet €2.64m
- Dr. De Sutter Jo Medical specialists activities Ypres · balance sheet €1.66m
- Dr. Ellen Verhulst Medical specialists activities Roeselare · balance sheet €1.78m
- Dokterskabinet CVH Medical specialists activities Ypres · balance sheet €1.92m
- Dokter Gubbelmans Hendrik Medical specialists activities Genk · balance sheet €2.31m
- Mind AF Medical specialists activities Duffel · balance sheet 19 €
- Dr. Harth André, orthopedisch chirurg - Dr. Van Trimpont Ingeborg, algemene geneeskunde Medical specialists activities Ghent · balance sheet €1.56m
Frequently asked questions about Revaprevent
What is the revenue of Revaprevent?
Revaprevent files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Revaprevent?
In Belgium, the VAT number is the company number prefixed with BE: BE0832428660 for Revaprevent, if the company is VAT-registered. Its company number (CBE) is 0832.428.660.
Where is the registered office of Revaprevent?
According to the CBE register, the registered office of Revaprevent is in 8800 Roeselare.
What is the equity of Revaprevent?
At the close of the 2025 financial year, the equity of Revaprevent amounts to 1,520,201 €, a solvency of 96.3% of total assets.
Who manages Revaprevent?
The register lists 3 active mandates at Revaprevent. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Revaprevent
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →